<p>(A and B) 1:10 dilutions of a 1:1 ratio of TRBV13-1:TRBV13-2 cells were transferred 1 day prior to RSV infection. Four days post-infection, the percentage of proliferating cells in the lung (A) and MLN (B) were identified by <i>in vivo</i> incorporation of BrdU during a two-hour incubation. <b>(</b>C and D) violet labeled TRBV13-1 and TRBV13-2 were co-transferred into CB6F1 mice prior to infection with RSV. Proliferation profiles of TRBV13-1and TRBV13-2 (C) in the MLN were evaluated at day 4 post-infection and percentage of dividing cells was determined (D).</p
<p>Percent of infected (GFP+) dendritic cell populations in the lung (A and B) and the posterior med...
<p>(<b>A</b>) Experimental design. 1×10<sup>5</sup> CFSE labeled M133 Tconv (Treg-depleted CD4 T cel...
<p>(<b>A</b>) Experimental design. M133 Tregs and M133 Tconv (Treg-depleted CD4 T cells) were mixed ...
<p>(A-D) CB6F1 mice received 10<sup>6</sup> of either TRBV13-1 or TRBV13-2 cells or a 1:1 mixture of...
<p>The indicted number of a 1:1 mix of TRBV13-1 and TRBV13-2 were transferred into CB6F1 mice one da...
<p>10<sup>6</sup> of TRBV13-1, TRBV13-2 cells, or a 1:1 mixture of both (mix) were transferred into ...
<p>10<sup>6</sup> or 10<sup>4</sup> cells were transferred into mice at input ratios of 2:1, 1:1, an...
<p>(A) 5×10<sup>6</sup> CFSE-labeled TRBV13-1 or TRBV13-2 cells were transferred in to naïve BALB/c ...
<p>10<sup>6</sup> of a 1:1 Mix of TRBV13-1 and TRBV13-2 Tg cells were transferred into mice. Seeding...
<p>Different numbers of a 1:1 mixture of TRBV13-2:TRBV13-1 cells were transferred 1 day prior to RSV...
<p>(A) BMDCs were transfected with <i>Kdm5b</i>-specific siRNA or non-targeting control, then infect...
<p><b>(a)</b> Adoptive transfer of pMHC-specific donor cells increases precursor of CD8 T effector c...
<p>A, Proportion of MLN containing infectious RRV. The numbers of mice analysed on each day are give...
<div><p>In this study, we compared two lines of transgenic CD8+ T cells specific for the same K<sup>...
<p>(<b>A</b>) Twice daily treatment with TVB-3166 (p.o.), Ribavirin (i.p.) or drug vehicle (p.o.) wa...
<p>Percent of infected (GFP+) dendritic cell populations in the lung (A and B) and the posterior med...
<p>(<b>A</b>) Experimental design. 1×10<sup>5</sup> CFSE labeled M133 Tconv (Treg-depleted CD4 T cel...
<p>(<b>A</b>) Experimental design. M133 Tregs and M133 Tconv (Treg-depleted CD4 T cells) were mixed ...
<p>(A-D) CB6F1 mice received 10<sup>6</sup> of either TRBV13-1 or TRBV13-2 cells or a 1:1 mixture of...
<p>The indicted number of a 1:1 mix of TRBV13-1 and TRBV13-2 were transferred into CB6F1 mice one da...
<p>10<sup>6</sup> of TRBV13-1, TRBV13-2 cells, or a 1:1 mixture of both (mix) were transferred into ...
<p>10<sup>6</sup> or 10<sup>4</sup> cells were transferred into mice at input ratios of 2:1, 1:1, an...
<p>(A) 5×10<sup>6</sup> CFSE-labeled TRBV13-1 or TRBV13-2 cells were transferred in to naïve BALB/c ...
<p>10<sup>6</sup> of a 1:1 Mix of TRBV13-1 and TRBV13-2 Tg cells were transferred into mice. Seeding...
<p>Different numbers of a 1:1 mixture of TRBV13-2:TRBV13-1 cells were transferred 1 day prior to RSV...
<p>(A) BMDCs were transfected with <i>Kdm5b</i>-specific siRNA or non-targeting control, then infect...
<p><b>(a)</b> Adoptive transfer of pMHC-specific donor cells increases precursor of CD8 T effector c...
<p>A, Proportion of MLN containing infectious RRV. The numbers of mice analysed on each day are give...
<div><p>In this study, we compared two lines of transgenic CD8+ T cells specific for the same K<sup>...
<p>(<b>A</b>) Twice daily treatment with TVB-3166 (p.o.), Ribavirin (i.p.) or drug vehicle (p.o.) wa...
<p>Percent of infected (GFP+) dendritic cell populations in the lung (A and B) and the posterior med...
<p>(<b>A</b>) Experimental design. 1×10<sup>5</sup> CFSE labeled M133 Tconv (Treg-depleted CD4 T cel...
<p>(<b>A</b>) Experimental design. M133 Tregs and M133 Tconv (Treg-depleted CD4 T cells) were mixed ...